Reply by Authors
J Urol
.
2020 Jun;203(6):1171.
doi: 10.1097/JU.0000000000000738.02.
Epub 2020 Mar 19.
Authors
Steven A Kaplan
1
,
Sender Herschorn
2
,
Kevin T McVary
3
,
David Staskin
4
,
Christopher Chapple
5
,
Steve Foley
6
,
Javier Cambronero Santos
7
,
Rita M Kristy
8
,
Nurul Choudhury
9
,
John Hairston
8
,
Carol R Schermer
8
Affiliations
1
Department of Urology, Icahn School of Medicine at Mount Sinai, New York City, New York.
2
Department of Surgery/Urology, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
3
Department of Urology, Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois.
4
Division of Urology, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts.
5
Department of Urology, Royal Hallamshire Hospital, Sheffield, UK.
6
Department of Urology, Royal Berkshire Hospital, Reading, UK.
7
Department of Urology, Infanta Leonor Hospital, Madrid, Spain.
8
Astellas Pharma Global Development Inc., Northbrook, Illinois.
9
Astellas Pharma Europe Ltd., Chertsey, UK.
PMID:
32191170
DOI:
10.1097/JU.0000000000000738.02
No abstract available
Publication types
Comment